Acrivon Therapeutics
Biotechnology Research • 
Cambridge, Massachusetts, United States • 51-100 Employees
Company overview
| Headquarters | 700 North Main Street, Cambridge, Massachusetts 02139, US |
| Phone number | +16172078979 |
| Website | |
| NAICS | 541714 |
| Keywords | Oncology, Drug Development, Proteomics, Precision Medicine, Therapeutics, Biomarker Discovery, Multiplex Tissue Imaging |
| Founded | 2018 |
| Employees | 51-100 |
| Socials |
Key Contacts at Acrivon Therapeutics
Syed M. Ali
Executive Director
Ayesha Murshid
Director
Jeanie Tang
Director Clinical Operations
Kirsten Hart
Senior Director, Head Of Human Resources
Lei Shi
Director And Head Of Ap3 Pathway Discovery
Sophia Khairalla
Associate Director, Assistant Controller
Ke Corey
Associate Director, Bioinformatics
Magnus Jakobsson
Director, Head Of Proteomics
Joelle Baddour-Sousounis
Associate Director, In Vivo Pharmacology
Sibgat Choudhury
Senior Director, Clinical Biomarker Development
Acrivon Therapeutics Email Formats
Acrivon Therapeutics uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@acrivon.com), used 89.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@acrivon.com | 89.1% |
{first initial}{last name} | jdoe@acrivon.com | 7.3% |
{first initial}{second initial}{last name} | jodoe@acrivon.com | 1.8% |
{f2}{last name} | {f2}doe@acrivon.com | 1.8% |
About Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in our wholly-owned subsidiary in Lund, Sweden.
Acrivon Therapeutics revenue & valuation
| Annual revenue | $6,673,290 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $21,400,000 |
| Total funding | $230,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Acrivon Therapeutics has 36 employees across 11 departments.
Departments
Number of employees
Funding Data
Explore Acrivon Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Acrivon Therapeutics Tech Stack
Discover the technologies and tools that power Acrivon Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Webmail
Miscellaneous
Programming languages
Blogs
Hosting
Analytics
SEO
Tag managers
United Kingdom
Germany
Philippines
Denmark
ChinaFrequently asked questions
4.8
40,000 users
